You have 8 free searches left this month | for more free features.

E0167

Showing 1 - 25 of 336

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pneumococcal Infections Trial in Worldwide (V114, Prevnar 13™, PNEUMOVAX™23)

Completed
  • Pneumococcal Infections
  • V114
  • +2 more
  • Palo Alto, California
  • +51 more
Sep 23, 2022

Small Cell Lung Carcinoma Trial in Worldwide (coformulation pembrolizumab/quavonlimab, lenvatinib, MK-4830)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • coformulation pembrolizumab/quavonlimab
  • +3 more
  • Gilbert, Arizona
  • +46 more
Jan 2, 2023

Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo, Topical corticosteroid)

Recruiting
  • Atopic Dermatitis
  • Caba, Buenos Aires, Argentina
  • +85 more
Nov 4, 2022

Acute Kidney Injury Trial in Worldwide (ANG-3777, Placebo)

Active, not recruiting
  • Acute Kidney Injury
  • Los Angeles, California
  • +39 more
Jul 9, 2021

Locally Advanced or Metastatic Unresectable Urothelial Cancer Trial in Worldwide (Sacituzumab Govitecan-hziy, Paclitaxel,

Recruiting
  • Locally Advanced or Metastatic Unresectable Urothelial Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Phoenix, Arizona
  • +210 more
Jul 28, 2022

Pneumococcal Infections Trial in Worldwide (Rotarix™, Infanrix™ hexa, V114)

Completed
  • Pneumococcal Infections
  • South Brisbane, Queensland, Australia
  • +59 more
Dec 1, 2021

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (CC-92480, Carfilzomib, Dexamethasone)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Mobile, Alabama
  • +130 more
Jan 27, 2023

NSCLC Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Pembrolizumab
  • +2 more
  • Anchorage, Alaska
  • +161 more
Oct 26, 2022

CMV Disease Trial in Worldwide (Letermovir, Valganciclovir, Acyclovir (ACV))

Completed
  • CMV Disease
  • Birmingham, Alabama
  • +93 more
Apr 8, 2022

Genetic Study of Schizophrenia

Recruiting
  • Schizoaffective Disorder
  • Schizophrenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Late Toxicities After Radiotherapy in Breast and Prostate Cancer

    Completed
    • Breast Cancer
    • Prostate Cancer
      • Montpellier, France
        CRLC Val d'Aurelle
      Nov 29, 2022

      Tobacco Use Disorder Trial in Baltimore, Burlington (Very low nicotine content cigarettes)

      Completed
      • Tobacco Use Disorder
      • Very low nicotine content cigarettes
      • Baltimore, Maryland
      • +1 more
      Nov 15, 2022

      Tobacco Use Disorder Trial in Baltimore, Burlington (Very low nicotine content cigarettes)

      Completed
      • Tobacco Use Disorder
      • Very low nicotine content cigarettes
      • Baltimore, Maryland
      • +1 more
      Nov 15, 2022

      Sinonasal Malignancies:, Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses Trial in Heidelberg (carbon ion

      Completed
      • Sinonasal Malignancies
      • Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses
      • carbon ion boost
      • Heidelberg, Germany
        Dept of Radiation Oncology, University of Heidelberg, INF 400
      Aug 29, 2022

      Head and Neck Tumor, Chemoradiotherapy Trial in Taichung (SZKJT(San-Zhong-Kui-Jian-Tang))

      Completed
      • Head and Neck Neoplasm
      • Chemoradiotherapy
      • Taichung, Taiwan
        China Medical University Hospital
      Oct 24, 2022

      Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (Pembrolizumab, Placebo, Cisplatin)

      Active, not recruiting
      • Gastric Cancer
      • Gastroesophageal Junction Cancer
      • Pembrolizumab
      • +7 more
      • Duarte, California
      • +170 more
      Aug 18, 2022

      Liver Transplant Trial (Normothermic machine perfusion (NMP) of steatotic liver)

      Not yet recruiting
      • Liver Transplant
      • Normothermic machine perfusion (NMP) of steatotic liver
      • (no location specified)
      Oct 12, 2023

      MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Luspatercept
      • Epoetin Alfa
      • Concord, California
      • +100 more
      Jul 20, 2023

      Larynx Cancer Stage I, Glottic Carcinoma Trial in Cairo (Hypofractionated single vocal cord irradiation, Whole laryngeal

      Recruiting
      • Larynx Cancer Stage I
      • Glottic Carcinoma
      • Hypofractionated single vocal cord irradiation
      • Whole laryngeal radiotherapy
      • Cairo, Egypt
        National Cancer Institute, Cairo University
      Jan 10, 2023

      Head and Neck Tumors Trial in Worldwide (biological, radiation, drug)

      Recruiting
      • Head and Neck Neoplasms
      • Pembrolizumab 200 mg
      • +4 more
      • La Jolla, California
      • +173 more
      Apr 7, 2022

      Prader-Willi Syndrome Trial in Aurora (Safe and Sound Protocol)

      Terminated
      • Prader-Willi Syndrome
      • Safe and Sound Protocol
      • Aurora, Colorado
        Integrated Listening Systems
      Feb 18, 2022

      Vitamin D and Microvascular Function in Postmenopausal Women

      Completed
      • Menopause Related Conditions
      • +2 more
      • Blood samples and Microvascular function assessment evaluated through laser-Doppler flowmetry by the LASER speckle contrast analysis (LASCA) device
      • Rio De Janeiro, Brazil
        State University of Rio de Janeiro
      Jun 2, 2022

      Colorectal Tumors Trial in Kaohsiung (single-port robotic surgery)

      Not yet recruiting
      • Colorectal Neoplasms
      • single-port robotic surgery
      • Kaohsiung, Taiwan
        Kaohsiung Chang Gung Memorial Hospital
      Jul 14, 2022

      Peripheral Vascular Diseases Trial in Worldwide (Any eligible commercially available Boston Scientific Corporation (BSC)

      Recruiting
      • Peripheral Vascular Diseases
      • Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device.
      • Jonesboro, Arkansas
      • +63 more
      Jan 17, 2023